3
Expanding RPRGs Minimum core functions: 1) Technical/managerial support for review and development of the annual work plans (AWP), drug requests, M&E activities, scaling up/down LF MDA, scaling up STH PC, and preparation of elimination dossier, for all PC diseases >> to be coordinated with NTD partners 2) Strategic advice on programmatic decisions for all PC diseases (TAS eligibility, stop-MDA, deworming frequency etc.) >> identify issues to be referred back to NTD STAG and its WGs

Expanding RPRGs

  • Upload
    thora

  • View
    29

  • Download
    0

Embed Size (px)

DESCRIPTION

Expanding RPRGs. Minimum core functions: Technical/managerial support for review and development of the annual work plans (AWP), drug requests, M&E activities, scaling up/down LF MDA, scaling up STH PC, and preparation of elimination dossier, for all PC diseases - PowerPoint PPT Presentation

Citation preview

Page 1: Expanding RPRGs

Expanding RPRGs

Minimum core functions:1) Technical/managerial support for review and development

of the annual work plans (AWP), drug requests, M&E activities, scaling up/down LF MDA, scaling up STH PC, and preparation of elimination dossier, for all PC diseases

>> to be coordinated with NTD partners

2) Strategic advice on programmatic decisions for all PC diseases (TAS eligibility, stop-MDA, deworming frequency etc.)

>> identify issues to be referred back to NTD STAG and its WGs

Page 2: Expanding RPRGs

Proposed interaction and technical support for the national programmes

MEC

MAC

WHO TEC

NTD STAG

WGs andSub-WGs

RPRGs

MOH

Page 3: Expanding RPRGs

Expanded RPRG Current RPRG

Review and provide guidance to countries in the development of their national plans for PC NTD control and elimination.

Review and provide guidance to countries in the development of national plans of action for LF

Conduct in-depth review and analysis of implementation and progress of the national programme.

Provide programmatic and logistical guidance to national programmes, including scaling up and scaling down of PC.

Review the implementation and progress of national programmes

Review the annual work plan of the national programme on the basis of the progress to date, based on which requests for drug donations of ALB, DEC, MEB and PZQ will be cleared by ROs.

Review also drug applications for ALB, DEC and PZQ make recommendations to WHO on approval.

AND each member is responsible for 'backing-up' a certain number of countries to ensure that programmatic and technical questions are addressed before RPRG meetings.

Provide technical guidance in the implementation of the recommendations of the Technical Advisory Group

Identify operational research issues for PC NTDs and refer them to NTD-STAG and its WGs.

Identify operational research issues arising out of implementation of LF programmes and refer issues to the relevant research institutions

Report matters related to achievement of NTD elimination targets by countries

Advise WHO on matters related to verifying the interruption of transmission of LF

Advocate and support WHO member states in seeking political commitments from governments and MoH for PC NTDs

Advocate and support the member states in seeking political commitments for the elimination of LF

Proposed ToR of expanded RPRGs